Table 3.
Journal impact factor and reported informed consent type in COVID-19 studies
| Impact factor | 0–5 | 5–10 | >10 | Data not available | ||||
| Total, n | 669 | 220 | 54 | 29 | ||||
| n | % | n | % | n | % | n | % | |
| Informed consent | 148 | 22.1 | 43 | 19.5 | 11 | 20.4 | 5 | 17.2 |
| Deferred consent | 2 | 0.3 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
| Verbal consent | 21 | 3.1 | 11 | 5.0 | 3 | 5.6 | 0 | 0.0 |
| Waiver of consent | 273 | 40.8 | 103 | 46.8 | 24 | 44.4 | 14 | 48.3 |
| Opt-out | 6 | 0.9 | 1 | 0.5 | 0 | 0.0 | 1 | 3.4 |
| Other consent types | 0 | 0.0 | 1 | 0.5 | 0 | 0.0 | 0 | 0.0 |
| No consent reported | 219 | 32.7 | 61 | 27.7 | 16 | 29.6 | 9 | 31.0 |
Data are numbers (n) and percentages (%).
We observed only one ‘other consent type’ that was not predefined, which was family consent.